Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Legend Biotech (LEGN) Gross Margin (2019 - 2025)

Historic Gross Margin for Legend Biotech (LEGN) over the last 7 years, with Q3 2025 value amounting to 80.68%.

  • Legend Biotech's Gross Margin rose 83200.0% to 80.68% in Q3 2025 from the same period last year, while for Sep 2025 it was 73.8%, marking a year-over-year increase of 160700.0%. This contributed to the annual value of 23412.65% for FY2024, which is 95086700.0% up from last year.
  • Latest data reveals that Legend Biotech reported Gross Margin of 80.68% as of Q3 2025, which was up 83200.0% from 81.16% recorded in Q2 2025.
  • Legend Biotech's 5-year Gross Margin high stood at 83.88% for Q2 2024, and its period low was 97963.15% during Q1 2021.
  • Its 5-year average for Gross Margin is 5117.33%, with a median of 57.62% in 2023.
  • Per our database at Business Quant, Legend Biotech's Gross Margin plummeted by -980064600bps in 2021 and then surged by 980205800bps in 2022.
  • Legend Biotech's Gross Margin (Quarter) stood at 35.43% in 2021, then skyrocketed by 118bps to 6.55% in 2022, then surged by 780bps to 57.62% in 2023, then rose by 28bps to 73.77% in 2024, then rose by 9bps to 80.68% in 2025.
  • Its Gross Margin was 80.68% in Q3 2025, compared to 81.16% in Q2 2025 and 79.0% in Q1 2025.